Clinical characteristics and predictors of prolonged hospitalization in patients with cosmetic botulinum toxin poisoning: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Clinical characteristics and predictors of prolonged hospitalization in patients with cosmetic botulinum toxin poisoning: a retrospective cohort study
Clinical Scorecard: Clinical Features and Factors Associated with Extended Hospital Stays in Cases of Cosmetic Botulinum Toxin Poisoning: A Retrospective Cohort Analysis
At a Glance
Category
Detail
Condition
Cosmetic Botulinum Toxin Poisoning
Key Mechanisms
Inhibition of acetylcholine release at the neuromuscular junction leading to cranial nerve palsies and bulbar dysfunction.
Target Population
Patients hospitalized for cosmetic botulinum toxin poisoning, predominantly women.
Care Setting
Inpatient hospital setting
Key Highlights
Median age of patients was 37 years; 97.93% were female.
Common symptoms included dizziness (89.66%), dysphagia (85.52%), and blurred vision (75.17%).
Dysphagia, slurred speech, and duration of antitoxin therapy were associated with prolonged hospitalization.
A nomogram was developed to estimate length of stay based on identified factors.
No in-hospital deaths occurred during the study.
Guideline-Based Recommendations
Diagnosis
Clinical diagnosis based on history of botulinum toxin injection and compatible symptoms.
Management
Inpatient management focusing on symptomatic treatment and antitoxin therapy.
Monitoring & Follow-up
Monitor for cranial nerve-related symptoms and duration of hospitalization.
Risks
Risk factors for prolonged hospitalization include dysphagia and slurred speech.
Patient & Prescribing Data
145 hospitalized patients with cosmetic botulinum toxin poisoning.
Antitoxin therapy duration is a key factor influencing hospitalization length.
Clinical Best Practices
Early identification of symptoms related to botulinum toxin poisoning.
Utilization of a nomogram for risk stratification in hospitalized patients.
